Another clinical study showed that the ratio of CD3+ and CD4+ cells and the CD4+/CD8+ ratio of non-small cell lung cancer patients increased after administering a Taxus decoction, suggesting that Taxus may boost the immunity of patients, thus prolonging their survival time (Ma et al., 2020). Here, CD4 is linked to non-small cell lung carcinoma.